Lauren Evoy Davis, MA

Researchers examined the time to fibrosis progression among patients with and without type 2 diabetes who had NAFLD.

A report explored associations between weight fluctuations and cardiovascular outcomes in individuals with type 2 diabetes who were treated with canagliflozin.

An investigation detailed associations between the dual risks of cholesterol and inflammation and all-cause mortality among individuals with cardiovascular disease.

Researchers evaluated the effect of ethnicity on infection risk among patients with type 2 diabetes and prediabetes.

Researchers evaluated differences in the association between obesity and cardiovascular disease.

Researchers sought to evaluate the effectiveness of social media-based interventions on weight, body mass index, waist circumference, fat, energy intake and physical activity.